Samy Hakroush Björn Tampe
10.3389/fimmu.2021.762006
Front Immunol
2021 Sep 30;12:762006.
anca-associated vasculitis (aav) acute kidney injury (aki) anti-neutrophil cytoplasmic antibody (anca) coronavirus disease 2019 (covid-19) pauci-immune crescentic glomerulonephritis (gn) rhabdomyolysis vaccination
CC BY
https://pubmed.ncbi.nlm.nih.gov/34659268/
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / pathology COVID-19 Vaccines / adverse effects Glomerulonephritis / pathology Rhabdomyolysis / pathology
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / pathology COVID-19 Vaccines / adverse effects Glomerulonephritis / pathology Rhabdomyolysis / pathology Case Reports Research Support, Non-U.S. Gov't Aged Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology Antibodies, Antineutrophil Cytoplasmic / blood Antibodies, Antineutrophil Cytoplasmic / immunology BNT162 Vaccine COVID-19 / prevention & control COVID-19 Vaccines / immunology Female Glomerulonephritis / diagnosis Glomerulonephritis / immunology Humans RNA, Messenger / immunology Rhabdomyolysis / diagnosis Rhabdomyolysis / immunology Antibodies, Antineutrophil Cytoplasmic COVID-19 Vaccines RNA, Messenger BNT162 Vaccine
PMC8514980
34659268
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination
2021